首页> 美国卫生研究院文献>Wiley-Blackwell Online Open >Replacement of an Indole Scaffold Targeting Human 15‐Lipoxygenase‐1 Using Combinatorial Chemistry
【2h】

Replacement of an Indole Scaffold Targeting Human 15‐Lipoxygenase‐1 Using Combinatorial Chemistry

机译:使用组合化学替代靶向人15-脂氧合酶-1的吲哚支架

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Human 15‐lipoxygenase‐1 (15‐LOX‐1) belongs to the class of lipoxygenases, which catalyze oxygenation of polyunsaturated fatty acids, such as arachidonic and linoleic acid. Recent studies have shown that 15‐LOX‐1 plays an important role in physiological processes linked to several diseases such as airway inflammation disease, coronary artery disease, and several types of cancer such as rectal, colon, breast and prostate cancer. In this study, we aimed to extend the structural diversity of 15‐LOX‐1 inhibitors, starting from the recently identified indolyl core. In order to find new scaffolds, we employed a combinatorial approach using various aromatic aldehydes and an aliphatic hydrazide tail. This scaffold‐hopping study resulted in the identification of the 3‐pyridylring as a suitable replacement of the indolyl core with an inhibitory activity in the micromolar range (IC 50=16±6 μm) and a rapid and efficient structure–activity relationship investigation.
机译:人15-脂氧合酶-1(15-LOX-1)属于脂氧合酶,可催化多不饱和脂肪酸(如花生四烯酸和亚油酸)的氧化。最近的研究表明,15‐LOX-1在与多种疾病(如气道炎症,冠状动脉疾病)和多种癌症(如直肠癌,结肠癌,乳腺癌和前列腺癌)有关的生理过程中起着重要作用。在这项研究中,我们旨在从最近确定的吲哚基核心开始,扩展15-LOX-1抑制剂的结构多样性。为了找到新的支架,我们采用了各种芳香醛和脂肪族酰肼尾巴的组合方法。这项脚手架跳跃研究的结果是,确定了3-吡啶基环可以取代吲哚基核,并具有微摩尔范围的抑制活性(IC 50 = 16±6μm),并且可以进行快速有效的构效关系研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号